Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy von KANG, Min H, REYNOLDS, C. Patrick

Volltext

miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma von Chava, Srinivas, Reynolds, C. Patrick, Pathania, Anup S., Gorantla, Santhi, Poluektova, Larisa Y., Coulter, Don W., Gupta, Subash C., Pandey, Manoj K., Challagundla, Kishore B.

Volltext

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Stu... von MATTHAY, Katherine K, REYNOLDS, C. Patrick, SEEGER, Robert C, SHIMADA, Hiroyuki, ADKINS, E. Stanton, HAAS-KOGAN, Daphne, GERBING, Robert B, LONDON, Wendy B, VILLABLANCA, Judith G

Volltext

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial von Kreissman, Susan G, Prof Dr, Seeger, Robert C, Prof, Matthay, Katherine K, Prof, London, Wendy B, PhD, Sposto, Richard, Prof, Grupp, Stephan A, Prof, Haas-Kogan, Daphne A, Prof, LaQuaglia, Michael P, Prof, Yu, Alice L, Prof, Diller, Lisa, Prof, Buxton, Allen, MS, Park, Julie R, Prof, Cohn, Susan L, Prof, Maris, John M, Prof, Reynolds, C Patrick, Prof, Villablanca, Judith G, Prof

Volltext

Microfluidic Separation of Lymphoblasts for the Isolation of Acute Lymphoblastic Leukemia Using the Human Transferrin Receptor as a Capture Target von Li, Wenjie, Zhang, Ye, Reynolds, C. Patrick, Pappas, Dimitri

Volltext

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma von Koneru, Balakrishna, Lopez, Gonzalo, Farooqi, Ahsan, Conkrite, Karina L, Nguyen, Thinh H, Macha, Shawn J, Modi, Apexa, Rokita, Jo Lynne, Urias, Eduardo, Hindle, Ashly, Davidson, Heather, Mccoy, Kristyn, Nance, Jonas, Yazdani, Vanda, Irwin, Meredith S, Yang, Shengping, Wheeler, David A, Maris, John M, Diskin, Sharon J, Reynolds, C Patrick

Volltext

Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641 von STROTHER, Douglas R, LONDON, Wendy B, MURRAY, Kevin, LAVEY, Robert S, MATTHAY, Katherine K, CASTLEBERRY, Robert, MARIS, John M, COHN, Susan L, SCHMIDT, Mary Lou, BRODEUR, Garrett M, SHIMADA, Hiroyuki, THORNER, Paul, COLLINS, Margaret H, TAGGE, Edward, ADKINS, Stanton, REYNOLDS, C. Patrick

Volltext

Reactive Oxygen Species-Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies von Makena, Monish R, Koneru, Balakrishna, Nguyen, Thinh H, Kang, Min H, Reynolds, C Patrick

Volltext

Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study von SHUSTERMAN, Suzanne, LONDON, Wendy B, GAN, Jacek, EICKHOFF, Jens, DESANTES, Kenneth B, COHN, Susan L, HECHT, Toby, GADBAW, Brian, REISFELD, Ralph A, MARIS, John M, SONDEL, Paul M, GILLIES, Stephen D, HANK, Jacquelyn A, VOSS, Stephan D, SEEGER, Robert C, REYNOLDS, C. Patrick, KIMBALL, Jennifer, ALBERTINI, Mark R, WAGNER, Barrett

Volltext

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models von Lowery, Caitlin D, Dowless, Michele, Renschler, Matthew, Blosser, Wayne, VanWye, Alle B, Stephens, Jennifer R, Iversen, Philip W, Lin, Aimee Bence, Beckmann, Richard P, Krytska, Kateryna, Cole, Kristina A, Maris, John M, Hawkins, Douglas S, Rubin, Brian P, Kurmasheva, Raushan T, Houghton, Peter J, Gorlick, Richard, Kolb, E Anders, Kang, Min H, Reynolds, C Patrick, Erickson, Stephen W, Teicher, Beverly A, Smith, Malcolm A, Stancato, Louis F

Volltext

Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres von Dagg, Rebecca A., Pickett, Hilda A., Neumann, Axel A., Napier, Christine E., Henson, Jeremy D., Teber, Erdahl T., Arthur, Jonathan W., Reynolds, C. Patrick, Murray, Jayne, Haber, Michelle, Sobinoff, Alexander P., Lau, Loretta M.S., Reddel, Roger R.

Volltext

Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709) von VILLABLANCA, Judith G, KRAILO, Mark D, AMES, Matthew M, REID, Joel M, REAMAN, Gregory H, REYNOLDS, Patrick C

Volltext

A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors von Thomas, Jacob S., El-Khoueiry, Anthony B., Maurer, Barry J., Groshen, Susan, Pinski, Jacek K., Cobos, Everardo, Gandara, David R., Lenz, Heinz J., Kang, Min H., Reynolds, C. Patrick, Newman, Edward M.

Volltext

Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial von Mohrbacher, Ann M, Yang, Allen S, Groshen, Susan, Kummar, Shivaani, Gutierrez, Martin E, Kang, Min H, Tsao-Wei, Denice, Reynolds, C Patrick, Newman, Edward M, Maurer, Barry J

Volltext

Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models von Nguyen, Thinh H, Koneru, Balakrishna, Wei, Sung-Jen, Chen, Wan Hsi, Makena, Monish Ram, Urias, Eduardo, Kang, Min H, Reynolds, C Patrick

Volltext

The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status von Trigg, Ricky M., Lee, Liam C., Prokoph, Nina, Jahangiri, Leila, Reynolds, C. Patrick, Amos Burke, G. A., Probst, Nicola A., Han, Miaojun, Matthews, Jamie D., Lim, Hong Kai, Manners, Eleanor, Martinez, Sonia, Pastor, Joaquin, Blanco-Aparicio, Carmen, Merkel, Olaf, de los Fayos Alonso, Ines Garces, Kodajova, Petra, Tangermann, Simone, Högler, Sandra, Luo, Ji, Kenner, Lukas, Turner, Suzanne D.

Volltext

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology... von Ozkaynak, M Fevzi, Gilman, Andrew L, London, Wendy B, Naranjo, Arlene, Diccianni, Mitchell B, Tenney, Sheena C, Smith, Malcolm, Messer, Karen S, Seeger, Robert, Reynolds, C Patrick, Smith, L Mary, Shulkin, Barry L, Parisi, Marguerite, Maris, John M, Park, Julie R, Sondel, Paul M, Yu, Alice L

Volltext

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines von Harenza, Jo Lynne, Diamond, Maura A., Adams, Rebecca N., Song, Michael M., Davidson, Heather L., Hart, Lori S., Dent, Maiah H., Fortina, Paolo, Reynolds, C. Patrick, Maris, John M.

Volltext

The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA von Kapranov, Philipp, St Laurent, Georges, Raz, Tal, Ozsolak, Fatih, Reynolds, C Patrick, Sorensen, Poul H B, Reaman, Gregory, Milos, Patrice, Arceci, Robert J, Thompson, John F, Triche, Timothy J

Volltext

Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay von Burrow, Trevor A, Koneru, Balakrishna, Macha, Shawn J, Sun, Wenyue, Barr, Frederic G, Triche, Timothy J, Reynolds, C Patrick

Volltext